Altay Regional Oncology Center

Barnaul 656049

0 studies enrolling now · 3 studies all time

What they study most

Castration-resistant Prostate Cancer, Metastatic Renal Cell Carcinoma, Prostate Cancer Metastatic, Renal Cell Carcinoma

Studies at this site

• Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma — Completed
• HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Stopped early
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early